1. Teo AR*, Nelson S, Strange W, Kubo H, Katsuki R, Kurahara K, Kanba S, Kato TA*. Social Withdrawal in Major Depressive Disorder: A Case-Control Study in Japan. Journal of Affective Disorders. 2020, 274, 1142-1146, doi:10.1016/j.jad.2020.06.011
2. Sagata N, Kano S, Ohgidani M, Inamine S, Sakai Y, Kato H, Masuda K, Nakahara T, Nakahara-Kido Makiko, Ohga S, Furue M, Sawa A, Kanba S, Kato TA*. Forskolin rapidly enhances neuron-like morphological change of directly induced-neuronal (iN) cells from neurofibromatosis type 1 (NF1) patients. Neuropsychopharmacology Reports. 2020, 40, 4, 396-400, doi: 10.1002/npr2.12144
3. Katsuki R, Tateno M, Kubo H, Kurahara K, Hayakawa K, Kuwano N, Kanba S, Kato TA*. Autism Spectrum Conditions in Hikikomori: A Pilot Case-Control Study. Psychiatry and Clinical Neurosciences. 2020,74, 12, 652-658, doi: 10.1111/pcn.13154
4. Setoyama D, Yoshino A, Takamura M, Okada G, Iwata M, Tsunetomi K, Ohgidani M, Kuwano N, Yoshimoto J, Okamoto Y, Yamawaki S, Kanba S, Kang D, Kato TA*. Personality classification enhances blood metabolome analysis and biotyping for major depressive disorders: two-species investigation. Journal of Affective Disorders. 2021, 279, 20-30, doi:10.1016/j.jad.2020.09.118
5. 加藤隆弘. 精神疾患におけるミクログリア活性化制御をターゲットとした創薬への期待. 老年精神医学雑誌. 2020, 31, 7, 700-710.
6. 加藤隆弘, 扇谷昌宏, 神庭重信. 精神疾患ミクログリア仮説からみた双極性障害とその橋渡し研究. 日本臨牀. 2020, 78, 10, 1654-1661.
7. Enomoto S, Kato TA*. Involvement of microglia in disturbed fear memory regulation: Possible microglial contribution to the pathophysiology of PTSD. Neurochemistry International. 2021, 142,104921, doi:10.1016/j.neuint.2020.104921
8. Erabi H, Okada G, Shibasaki C, Setoyama D, Kang D, Takamura M, Yoshino A, Fuchikami M, Kurata A, Kato TA, Yamawaki S, Okamoto Y*. Kynurenic acid is a potential overlapped biomarker between diagnosis and treatment response for depression from metabolome analysis. Scientific Reports. 2020, 10, 1, 16822, doi: 10.1038/s41598-020-73918-z. <謝辞の記載を誤記入したため>